Why I'd Still Buy This 10%-Yielding Dividend Stock After the Fed's Latest Hike

The Fed raised the federal-funds rate 25bps to 3.75%-4.00%, with markets expecting additional hikes as inflation remains above 3% versus the 2% target. Ares Capital has 74% of its $15.9B debt floating rate, creating funding-cost pressure, but 71% of its $29.3B investment portfolio is floating rate, which management expects to more than offset higher interest expense. Shares are nearly 10% below their high, lifting the dividend yield above 10%, while Ares recently issued $750M of 6.25% fixed-rate notes due 2033.

Analysis

The relevant sensitivity is not the headline yield but ARCC’s net investment income spread after asset-level rate floors, liability resets, and prepayments. A further 50-75bp of tightening should initially support recurring earnings because the earning-asset base reprices faster in aggregate, but that benefit likely peaks within 1-3 quarters as higher debt-service burdens migrate into weaker middle-market borrowers. The market will discount ARCC on expected future credit losses and NAV marks well before reported non-accruals rise.

ARCC’s scale and sponsor relationships should make it a relative winner versus smaller BDCs when borrowers need amendments, rescue capital, or refinancing; that can widen origination spreads and improve deal selectivity. The offset is that a prolonged restrictive-rate regime reduces exit activity and portfolio-company EBITDA, raising PIK income and delaying realizations—both warning signs that stated income is becoming lower quality. A more useful relative expression is long ARCC or BXSL versus FSK, where underwriting and portfolio-quality dispersion matters more than incremental base-rate income.

Consensus may be too focused on whether the dividend is covered this quarter. The higher-risk scenario is not an immediate distribution cut, but a 6-18 month combination of NAV erosion, rising non-accruals, and a wider discount-to-NAV that overwhelms carry. Falsify the cautious view if ARCC maintains stable NAV per share, limits non-accrual growth, and reports cash interest income—not PIK—as the primary source of incremental NII through the next two earnings cycles.

Key Decisions for Investors

• Do not chase ARCC solely on a double-digit indicated yield; accumulate only on a 5-8% pullback or at a material discount to latest reported NAV, with a 6-12 month horizon. Target total return is carry plus discount-to-NAV normalization; exit if NAV declines for two consecutive quarters while non-accruals rise.
• Initiate a 3-6 month relative-value pair: long ARCC / short FSK, sized beta-neutral. The thesis is a flight toward scale, underwriting quality, and funding access if tightening exposes weaker sponsor-backed credits; close if FSK’s NAV trend and non-accrual performance converge with ARCC’s.
• Monitor ARCC’s next two reports for cash-versus-PIK income mix, non-accrual percentage, realized losses, and dividend coverage. A meaningful increase in PIK or deterioration in NAV is an alert to reduce exposure rather than average down.
• For broad rate-risk hedging around a renewed hawkish repricing, pair any ARCC long with a modest long in short-duration Treasury exposure rather than assuming the BDC is a pure beneficiary of higher policy rates; credit-spread widening, not the terminal policy rate, is the principal downside variable.